Hexima’s lead product, HXP124, is a topical antifungal treatment for onychomycosis or fungal nail infections.

Now Recruiting

Hexima is recruiting volunteers for clinical trials of HXP124. Click below to find out more and to register your interest.

Latest NailMail Newsletter

NailMail is Hexima’s regular quarterly newsletter to shareholders, investors and interested parties.

External Links

Take a look at these useful links to learn more about our industry.

Australian Academy of Science
Australian Science Media Centre logo